Does cancer run in families? Sometimes, but most cancers are not directly inherited. Around 5%–10% of cancers are believed to result from harmful genetic changes passed from a parent. In other families, several relatives may develop cancer because they share certain behaviours, environmental exposures, or common risk factors.
A family history of cancer therefore does not mean that you will inevitably develop the disease. It means your medical oncologist may need to examine the types of cancer in your family, the ages at diagnosis, and which relatives were affected before recommending genetic counseling, testing, or earlier screening.
Key Points at a Glance
| Question | Direct answer |
|---|---|
| Is most cancer hereditary? | No. Only about 5%–10% of cancers are linked to inherited harmful gene changes. |
| Can cancer come from either parent? | Yes. A cancer risk variant may be inherited from the mother’s or father’s side. |
| Does inheriting a mutation guarantee cancer? | No. It raises risk but does not determine whether or when cancer will develop. |
| Who may need genetic counseling? | People with young age cancers, several affected relatives, rare cancers, or related cancers across generations. |
| Can screening reduce risk? | Screening does not prevent every cancer, but it may detect some cancers earlier when treatment can be more effective. |
These figures describe inherited susceptibility, not certainty. Personal risk depends on the specific gene, family history, age, sex, lifestyle, and other medical factors.
Does Cancer Run in Families Because of Genetics?
Cancer may appear repeatedly in a family for three broad reasons: an inherited gene variant, shared risk factors, or coincidence.
The pattern matters more than the simple presence of cancer in one relative. A single family member diagnosed with a common cancer at an older age usually has a different significance from several close relatives developing related cancers before age 50.
Hereditary, familial, and sporadic cancer compared
| Cancer pattern | What it means | Common clues |
| Hereditary cancer | Cancer risk is increased by a harmful gene variant passed through a family. | Early diagnosis, multiple generations affected, rare cancers, bilateral cancers, or multiple cancers in one person |
| Familial cancer | Cancer occurs more often in a family, but no single inherited variant has been confirmed. | Several relatives affected, possibly due to a combination of genes, lifestyle, and environment |
| Sporadic cancer | Cancer develops mainly from genetic changes acquired during life. | No strong family pattern; often associated with ageing, exposures, infections, lifestyle, or chance |
Cancer itself is not passed from one person to another through a family. What may be inherited is a genetic change that increases susceptibility to certain cancers.
What Is the Role of Genetics in Cancer?
Genes contain instructions that help cells grow, divide, repair damage, and die at the appropriate time. Cancer develops when genetic changes disrupt these normal controls and allow abnormal cells to grow uncontrollably.
All cancers involve genetic changes in cells, but not all of those changes are inherited.
Germline mutations versus somatic mutations
| Type of genetic change | Where it is found | Can it be inherited? | Why it matters |
| Germline variant | Usually present in nearly every cell from birth | Yes | May increase cancer risk for the individual and blood relatives |
| Somatic or tumour mutation | Found only in the tumour or affected tissue | No | May influence how the cancer behaves and which treatment may work |
This distinction is important. A mutation identified during tumour testing does not automatically mean the mutation was inherited. A separate blood or saliva test may be needed to determine whether it is a germline variant.
How Much Cancer Is Hereditary?
The National Cancer Institute estimates that approximately 5%-10% of cancers are caused by harmful inherited genetic changes. The remaining cancers are mainly associated with genetic damage acquired during life, ageing, environmental factors, infections, lifestyle, or a combination of influences.
Some inherited variants can create a much higher lifetime risk for particular cancers.
For example:
| Genetic finding | Estimated cancer risk |
| Harmful BRCA1 or BRCA2 variant | More than 60% lifetime risk of female breast cancer |
| Harmful BRCA1 variant | Approximately 39%–58% lifetime risk of ovarian cancer |
| Harmful BRCA2 variant | Approximately 13%–29% lifetime risk of ovarian cancer |
| Autosomal dominant cancer-risk variant in a parent | Each child usually has a 50% chance of inheriting the variant |
A 50% chance of inheriting a variant does not mean a 50% chance of developing cancer. The actual cancer risk depends on the gene’s penetrance, the type of variant, age, sex, lifestyle, and other modifying factors.
What Family History Patterns Suggest Hereditary Cancer Risk?
One cancer diagnosis in a large family does not automatically indicate an inherited cancer syndrome. Doctors look for patterns that are unusual for sporadic cancer.
Genetic counseling may be considered when a personal or family history includes:
- Cancer diagnosed at an unusually young age, such as colorectal cancer before age 50
- Several close relatives with the same or related cancers
- Breast and ovarian cancers occurring on the same side of a family
- Colorectal and endometrial cancers occurring in the family
- More than one primary cancer in the same person
- Cancer affecting both breasts, both kidneys, or other paired organs
- Male breast cancer
- Ovarian, pancreatic, or metastatic prostate cancer
- A relative with a confirmed harmful cancer risk variant
- Rare tumours associated with hereditary syndromes
- Similar cancers appearing across several generations
These clues do not prove that a mutation is present. They indicate that a structured genetic risk assessment may be useful.
For a symptom-focused discussion, read this guide to family cancer warning signs.
Which Cancers Can Be Hereditary?
Several cancers may be associated with inherited cancer syndromes. However, most people who develop these cancers do not necessarily have an inherited mutation.
| Hereditary syndrome | Common genes | Cancers that may be associated |
| Hereditary breast and ovarian cancer syndrome | BRCA1, BRCA2, PALB2 and others | Breast, ovarian, pancreatic, prostate and male breast cancer |
| Lynch syndrome | MLH1, MSH2, MSH6, PMS2, EPCAM | Colorectal, endometrial, ovarian, stomach, urinary tract and other cancers |
| Familial adenomatous polyposis | APC | Colorectal and some upper gastrointestinal cancers |
| Li-Fraumeni syndrome | TP53 | Breast cancer, sarcoma, brain tumours, leukaemia and adrenal cancer |
| Hereditary diffuse gastric cancer | CDH1, CTNNA1 | Diffuse gastric cancer and lobular breast cancer |
| Multiple endocrine neoplasia type 2 | RET | Medullary thyroid cancer and certain endocrine tumours |
| Von Hippel–Lindau syndrome | VHL | Kidney cancer and several benign or malignant tumours |
| Hereditary retinoblastoma | RB1 | Retinoblastoma and increased risk of certain later cancers |
The exact cancer spectrum varies by gene. A multigene panel should therefore be selected according to a person’s medical and family history rather than ordered without clinical guidance.
Is Cancer Hereditary From the Mother or Father?
A harmful cancer-risk variant can be inherited from either the mother or the father.
The paternal side of the family is sometimes overlooked in discussions about breast and ovarian cancer. However, a father can carry and pass a BRCA-related variant even if he has never developed cancer himself.
Similarly, a woman can inherit a variant associated with prostate cancer risk and pass it to her sons. Doctors should therefore review both maternal and paternal relatives when creating a family cancer history.
Many hereditary cancer syndromes follow an autosomal dominant inheritance pattern. In these syndromes, a parent carrying the variant generally has a 50% chance of passing it to each child, regardless of the child’s sex.
What Is Genetic Counseling for Cancer?
Genetic counseling is a structured consultation that helps a person understand whether their medical or family history suggests an inherited cancer syndrome.
It is not simply a blood test appointment. Counseling helps patients understand:
- Whether testing is medically appropriate
- Which family member should be tested first
- Which genes should be included
- Possible positive, negative, or uncertain results
- How a result may affect screening and treatment
- What the information could mean for relatives
- Possible psychological, family, financial, and privacy concerns
Cancer genetics risk assessment usually combines medical history, a family pedigree, education, risk communication, and recommendations for appropriate follow-up.
Who Should Have Genetic Testing for Hereditary Cancer?
Genetic testing is not required for every person who has a relative with cancer.
Testing is more likely to be useful when a person has a diagnosis or family pattern associated with inherited susceptibility. Current clinical guidance commonly considers testing for people with diagnoses such as ovarian cancer, pancreatic cancer, male breast cancer, metastatic prostate cancer, triple negative breast cancer, or colorectal cancer at a young age.
Eligibility may also depend on tumour characteristics, ancestry, the number of relatives affected, and whether a harmful variant is already known in the family.
A consultation with a medical oncologist or genetics-trained professional helps determine whether testing is appropriate and which test provides meaningful information.
Who Should Be Tested First in a Family?
When possible, testing should begin with a relative who has developed cancer.
An affected person is more likely to provide an informative result. When a harmful variant is identified, other relatives can then have targeted testing for that specific variant.
Testing an unaffected relative first may produce an “uninformative negative.” This means no harmful variant was detected, but it remains unclear whether the family has an unidentified inherited risk.
How Is Genetic Testing Performed?
Inherited cancer testing is generally performed using a blood or saliva sample.
The laboratory may examine:
- A specific variant already identified in the family
- A focused group of genes connected with a particular cancer pattern
- A broader multigene panel covering several hereditary syndromes
A larger panel is not automatically better. Broader testing may identify unexpected findings or variants whose significance is not yet known.
This is one reason direct-to-consumer testing should not replace clinical assessment. Some consumer tests examine only a limited selection of variants and may provide false reassurance when the result is negative.
What Do Genetic Test Results Mean?
Genetic test results require careful interpretation.
Positive or pathogenic result
A positive result means the laboratory identified a harmful or likely harmful variant associated with increased cancer risk.
It may influence:
- Screening age and frequency
- Risk-reducing medication or surgery
- Treatment selection for an existing cancer
- Testing recommendations for blood relatives
- Reproductive and family planning discussions
A positive result does not confirm that a healthy person has cancer, nor does it predict exactly when cancer will occur.
True negative result
A true negative occurs when a specific harmful variant is already known in the family, but the person tested did not inherit it.
The individual usually does not carry the extra risk associated with that familial variant. However, ordinary age-related and lifestyle related cancer risks still remain.
Uninformative negative result
No harmful variant was identified, but no specific familial mutation was previously known.
This result cannot completely exclude hereditary risk. Screening may still be recommended according to the family history.
Variant of uncertain significance
A variant of uncertain significance, or VUS, is a genetic change for which available evidence cannot yet determine whether it raises cancer risk.
A VUS should generally not be treated like a confirmed harmful mutation. Most uncertain variants are eventually reclassified as benign, although continued follow-up with the testing provider is important.
How Can Hereditary Cancer Risk Change Screening?
People with an inherited cancer risk variant may need screening that begins earlier, occurs more frequently, or uses different tests from those recommended for average risk individuals.
Depending on the gene and cancer risk, a care plan may include:
- Earlier mammography or breast MRI
- More frequent colonoscopy
- Screening for cancers connected with the identified syndrome
- Clinical examinations at shorter intervals
- Risk-reducing medication
- Preventive surgery in carefully selected high risk situations
- Testing of adult blood relatives
There is no single hereditary cancer screening schedule. Recommendations must be personalised according to the gene, the person’s age, previous cancers, medical history, and current evidence.
The website’s step-by-step cancer screening guide provides an overview of commonly used screening methods. Individual screening decisions should still be discussed with a qualified clinician.
Can Genetic Information Affect Cancer Treatment?
Yes. For a person already diagnosed with cancer, inherited and tumour specific genetic findings may sometimes influence treatment.
Certain genetic findings can help oncologists determine whether a patient may benefit from a targeted therapy. They may also indicate an increased risk of developing another primary cancer and guide follow-up care.
However, treatment decisions depend on more than one gene result. The cancer type, stage, pathology, tumour biomarkers, previous treatment, general health, and patient preferences must all be considered.
Information about available cancer treatment services includes chemotherapy, immunotherapy, targeted therapy and screening support.
Can You Prevent Hereditary Cancer?
No strategy can guarantee that a person will never develop cancer. Inherited risk also cannot be removed through lifestyle changes alone.
However, knowing about increased risk can create opportunities for earlier screening, risk-reducing treatment, and informed health decisions.
General cancer-risk reduction includes:
- Avoiding smoking and smokeless tobacco
- Maintaining a healthy body weight
- Staying physically active
- Eating a balanced diet rich in vegetables, fruits, whole grains and fibre
- Limiting or avoiding alcohol
- Protecting skin from excessive ultraviolet exposure
- Receiving HPV and hepatitis B vaccination when medically appropriate
- Managing cancer-associated infections
- Attending recommended cancer screening
- Seeking medical assessment for persistent or unexplained symptoms
These actions reduce risk; they do not eliminate it. A healthy lifestyle should complement—not replace—gene-specific surveillance.
How Should You Record Your Family Cancer History?
Before meeting a doctor, gather information about relatives on both sides of the family.
Record:
- The relative’s relationship to you
- The type of cancer
- Age at diagnosis
- Whether more than one cancer occurred
- Whether paired organs were affected
- Pathology reports, when available
- Genetic test results already present in the family
- Age and cause of death, when known
Information covering at least three generations is particularly helpful. Include parents, children, siblings, grandparents, aunts, uncles, nieces, nephews and first cousins where possible.
Do not delay a consultation because some details are unavailable. Even an incomplete history can help a clinician identify whether further assessment is appropriate.
When Should You Consult a Medical Oncologist?
Consider discussing your family history with a medical oncologist when:
- Several close relatives have developed cancer
- A relative was diagnosed at a young age
- Breast, ovarian, pancreatic or prostate cancers appear together
- Colorectal and endometrial cancers occur in the same family
- A relative has male breast cancer
- One person has developed multiple primary cancers
- A harmful genetic variant has been identified in the family
- You already have cancer and want to understand whether genetics may affect treatment or relatives
A medical oncologist can review the full clinical context and coordinate referrals for genetic counseling, testing, screening, and multidisciplinary care.
You may learn more about Dr. Sudip Shrestha’s medical oncology background or schedule an oncology consultation.
Frequently Asked Questions
Which type of cancer is hereditary?
Breast, ovarian, colorectal, endometrial, pancreatic, prostate, gastric, thyroid, kidney and some childhood cancers may be associated with inherited syndromes. However, most cases of these cancers are not hereditary. Testing is based on the individual diagnosis and family pattern.
How can I avoid getting cancer?
Cancer cannot be prevented with certainty. Risk may be reduced by avoiding tobacco, maintaining a healthy weight, staying active, limiting alcohol, receiving recommended vaccinations, protecting against excessive sun exposure and completing age- and risk-appropriate screening.
Which cancer is the most hereditary?
There is no single universally “most hereditary” cancer. Among common adult cancers, ovarian cancer has one of the clearest familial components; the National Cancer Institute notes that approximately 20% of ovarian cancers are familial. Prostate cancer is also highly heritable, although much of its inherited risk comes from many common genetic variants rather than one high-risk mutation.
Is cancer hereditary from the mother or father?
Cancer-risk variants can be inherited from either the mother or the father. Both maternal and paternal family histories should be reviewed, even for cancers that mainly affect one sex.
What are the seven warning signs of cancer?
The traditional seven warning signs are:
- Change in bowel or bladder habits
- A sore that does not heal
- Unusual bleeding or discharge
- A thickening or lump
- Indigestion or difficulty swallowing
- An obvious change in a mole or wart
- A persistent cough or hoarseness
These signs are not proof of cancer and are not a complete symptom list. Unexplained weight change, persistent fatigue, pain, swelling and other lasting body changes may also require medical evaluation.
Is cancer 100% genetic?
Cancer always involves genetic changes inside cells, but it is not always hereditary. Most cancer-causing changes develop during life because of ageing, exposures, infections, lifestyle factors or random errors during cell division. Only around 5%–10% of cancers are linked to harmful inherited variants.
Does a positive genetic test mean I already have cancer?
No. A positive inherited-risk test means a harmful variant was identified. It indicates increased susceptibility, not a current cancer diagnosis. Clinical examinations, imaging or other diagnostic tests are required to detect cancer.
Can I still be at high risk after a negative test?
Yes. A negative test may be uninformative when no familial variant is known, when the relevant gene was not included, or when science has not yet identified the family’s underlying cause. Screening may still be based on personal and family history.
Should healthy family members get tested immediately?
Not necessarily. When possible, testing usually begins with a relative who has had cancer. If a harmful variant is found, healthy relatives can receive targeted testing for that specific variant.
Conclusion
Cancer can run in families, but a family history is not a prediction of what will happen to every relative.
The most useful approach is to identify the pattern: which cancers occurred, who was affected, and how young they were at diagnosis. Genetic counseling can then determine whether testing is appropriate and help families understand the possible results.
When inherited risk is identified, personalised screening and prevention planning may support earlier detection and better informed care. Even when testing is negative, a strong family history may still justify closer monitoring.
For an individual assessment, contact Dr. Sudip Shrestha to discuss family history, screening options and appropriate oncology care.
About the Author
Dr. Sudip Shrestha, MD is a Senior Consultant Medical Oncologist and Founder and Executive Chairman of Nepal Cancer Hospital & Research Center. His official profile lists an MBBS from JIPMER, an MD in Internal Medicine from Tribhuvan University, and postgraduate training in Medical Oncology from Rajiv Gandhi Cancer Institute & Research Centre, Delhi.
Medical disclaimer: This content is intended for general patient education. It does not diagnose cancer, determine individual genetic risk, or replace consultation with a qualified doctor, medical oncologist or genetics professional.
